Discussion of established combinations and new combinations in multiple myeloma (2:3)

Fredrik Schjesvold | ASH 2017 | Hematologi / Onkologi | Juni 13, 2018

Föreläsare: Fredrik Schjesvold

Watch dr. Fredrik Schjesvold take you through NEW documentation for the regimen RVD liteto elderly patients. In the second part of the MEDtalk he will present the ALKYONE data showing a benefit for daratumab added a VRD regimen.